Cargando…
The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension
BACKGROUND: Pulmonary vascular diseases are increasingly recognised as important clinical conditions. Pulmonary hypertension associated with a range of aetiologies is difficult to treat and associated with progressive morbidity and mortality. Current therapies for pulmonary hypertension include phos...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831997/ https://www.ncbi.nlm.nih.gov/pubmed/20209098 http://dx.doi.org/10.1371/journal.pone.0009526 |
_version_ | 1782178308552654848 |
---|---|
author | Harrington, Louise S. Moreno, Laura Reed, Anna Wort, Stephen J. Desvergne, Béatrice Garland, Christopher Zhao, Lan Mitchell, Jane A. |
author_facet | Harrington, Louise S. Moreno, Laura Reed, Anna Wort, Stephen J. Desvergne, Béatrice Garland, Christopher Zhao, Lan Mitchell, Jane A. |
author_sort | Harrington, Louise S. |
collection | PubMed |
description | BACKGROUND: Pulmonary vascular diseases are increasingly recognised as important clinical conditions. Pulmonary hypertension associated with a range of aetiologies is difficult to treat and associated with progressive morbidity and mortality. Current therapies for pulmonary hypertension include phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, or prostacyclin mimetics. However, none of these provide a cure and the clinical benefits of these drugs individually decline over time. There is, therefore, an urgent need to identify new treatment strategies for pulmonary hypertension. METHODOLOGY/PRINCIPAL FINDINGS: Here we show that the PPARβ/δ agonist GW0742 induces vasorelaxation in systemic and pulmonary vessels. Using tissue from genetically modified mice, we show that the dilator effects of GW0742 are independent of the target receptor PPARβ/δ or cell surface prostacyclin (IP) receptors. In aortic tissue, vascular relaxant effects of GW0742 were not associated with increases in cGMP, cAMP or hyperpolarisation, but were attributed to inhibition of RhoA activity. In a rat model of hypoxia-induced pulmonary hypertension, daily oral dosing of animals with GW0742 (30 mg/kg) for 3 weeks significantly reduced the associated right heart hypertrophy and right ventricular systolic pressure. GW0742 had no effect on vascular remodelling induced by hypoxia in this model. CONCLUSIONS/SIGNIFICANCE: These observations are the first to show a therapeutic benefit of ‘PPARβ/δ’ agonists in experimental pulmonary arterial hypertension and provide pre-clinical evidence to favour clinical trials in man. |
format | Text |
id | pubmed-2831997 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28319972010-03-06 The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension Harrington, Louise S. Moreno, Laura Reed, Anna Wort, Stephen J. Desvergne, Béatrice Garland, Christopher Zhao, Lan Mitchell, Jane A. PLoS One Research Article BACKGROUND: Pulmonary vascular diseases are increasingly recognised as important clinical conditions. Pulmonary hypertension associated with a range of aetiologies is difficult to treat and associated with progressive morbidity and mortality. Current therapies for pulmonary hypertension include phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, or prostacyclin mimetics. However, none of these provide a cure and the clinical benefits of these drugs individually decline over time. There is, therefore, an urgent need to identify new treatment strategies for pulmonary hypertension. METHODOLOGY/PRINCIPAL FINDINGS: Here we show that the PPARβ/δ agonist GW0742 induces vasorelaxation in systemic and pulmonary vessels. Using tissue from genetically modified mice, we show that the dilator effects of GW0742 are independent of the target receptor PPARβ/δ or cell surface prostacyclin (IP) receptors. In aortic tissue, vascular relaxant effects of GW0742 were not associated with increases in cGMP, cAMP or hyperpolarisation, but were attributed to inhibition of RhoA activity. In a rat model of hypoxia-induced pulmonary hypertension, daily oral dosing of animals with GW0742 (30 mg/kg) for 3 weeks significantly reduced the associated right heart hypertrophy and right ventricular systolic pressure. GW0742 had no effect on vascular remodelling induced by hypoxia in this model. CONCLUSIONS/SIGNIFICANCE: These observations are the first to show a therapeutic benefit of ‘PPARβ/δ’ agonists in experimental pulmonary arterial hypertension and provide pre-clinical evidence to favour clinical trials in man. Public Library of Science 2010-03-04 /pmc/articles/PMC2831997/ /pubmed/20209098 http://dx.doi.org/10.1371/journal.pone.0009526 Text en Harrington et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Harrington, Louise S. Moreno, Laura Reed, Anna Wort, Stephen J. Desvergne, Béatrice Garland, Christopher Zhao, Lan Mitchell, Jane A. The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title | The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title_full | The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title_fullStr | The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title_full_unstemmed | The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title_short | The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension |
title_sort | pparβ/δagonist gw0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831997/ https://www.ncbi.nlm.nih.gov/pubmed/20209098 http://dx.doi.org/10.1371/journal.pone.0009526 |
work_keys_str_mv | AT harringtonlouises thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT morenolaura thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT reedanna thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT wortstephenj thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT desvergnebeatrice thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT garlandchristopher thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT zhaolan thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT mitchelljanea thepparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT harringtonlouises pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT morenolaura pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT reedanna pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT wortstephenj pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT desvergnebeatrice pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT garlandchristopher pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT zhaolan pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension AT mitchelljanea pparbdagonistgw0742relaxespulmonaryvesselsandlimitsrighthearthypertrophyinratswithhypoxiainducedpulmonaryhypertension |